Join our Clinical Trials to Make LINDA Available Worldwide.
Your participation in LINDA's clinical trials gets us one step closer to making preventative breast cancer accessible to women across the globe.
Medical Breakthroughs are a Group Effort
LINDA's international phase III cancer clinical research trials aim to confirm the safety and efficacy of our groundbreaking technology in improving the prognosis, survival, and quality of life of breast cancer patients worldwide.
Eligibility Criteria
To participate in a LINDA trial, volunteers must be over 20 years of age, assigned female at birth (AFAB), and currently associated with a cancer centre in Canada.
Current Locations
LINDA is currently conducting trials in Canada with the Princess Margaret Cancer Centre, the nation’s largest comprehensive cancer. More trials may become available in the future. Trials are also continuing in Brazil.
Trial Phase
LINDA is currently in phase III of clinical research. Our trial protocol has been reviewed and approved by the Canadian Research Ethics Board and is underway at institutions in Canada.
Additional Information
If you are interested in volunteering for a future clinical trial, supporting LINDA's development via research, or partnering with LINDA for a clinical trial at your institution, fill out our form below.
Support our Clinical Trials
Fill out the form below and let us know how you want to participate in LINDA's clinical trials.
Clinical Trial Locations
Find a clinical trial location near you.
Toronto, Canada
São Paulo, Brazil
Frequently asked Questions
Find answers to common questions about participating in our clinical trials.
A clinical trial is medical research that involves the participation of volunteers. The goal of a clinical trial is to determine whether the treatment, technology, or behavior approach under study is safe and effective.
Clinical trials are conducted in phases. Once the safety and efficacy of the technology or treatment has been verified in earlier phases, Phase III trials test thousands of people, sometimes in different regions and countries, so that the technology can be fully approved and released to the market.
All our clinical trials are approved and monitored by institutional review boards, and adhere to the highest standards for health, safety, and ethics.
The best way of participating in a LINDA clinical trial is to discuss the opportunity with your care team.
During the trial, your team of doctors and health care providers will conduct any exams or tests related to the study. They will usually share your results with you and provide any additional information or follow-up required. This describes a typical trial process, however we recommend discussing the specifics of your trial with your doctor for more information.
Your informed consent is paramount to your participation, and you can withdraw from our clinical trials at any time. The research team will provide any necessary information and guidance to support your decision.
LINDA is a novel technology, and our capabilities will expand over time. Our initial trials focus on an AFAB patient cohort so that our solution can receive approval to serve a wide population of vulnerable individuals quickly. But we know that breast cancer doesn’t discriminate, and we will be evolving to serve a broader patient population in the future.